Natural killer cell-based therapies

le Romagné, François, Vivier, Eric
Foilsithe 2011

What lessons can be learned from γδ T cell-based cancer immunotherapy trials?

le Fournié, Jean-Jacques, Sicard, Hélène, Poupot, Mary, Bezombes, Christine, Blanc, Amandine, Romagné, François, Ysebaert, Loic, Laurent, Guy
Foilsithe 2013

Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor (CD158b)

le Cambiaggi, Anna, Verthuy, Christophe, Naquet, Philippe, Romagné, François, Ferrier, Pierre, Biassoni, Roberto, Moretta, Alessandro, Moretta, Lorenzo, Vivier, Eric
Foilsithe 1997

Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo

le Sola, Caroline, André, Pascale, Lemmers, Céline, Fuseri, Nicolas, Bonnafous, Cécile, Bléry, Mathieu, Wagtmann, Nicolai R., Romagné, François, Vivier, Eric, Ugolini, Sophie
Foilsithe 2009

Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model

le Sola, Caroline, Chanuc, Fabien, Thielens, Ariane, Fuseri, Nicolas, Morel, Yannis, Bléry, Mathieu, André, Pascale, Vivier, Eric, Graziano, Robert, Romagne, Francois, Bonnafous, Cécile
Foilsithe 2013

Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells

le Ruggeri, Loredana, Urbani, Elena, André, Pascale, Mancusi, Antonella, Tosti, Antonella, Topini, Fabiana, Bléry, Mathieu, Animobono, Lucia, Romagné, François, Wagtmann, Nicolai, Velardi, Andrea
Foilsithe in Haematologica (2016)

Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in N...

le Rey, Jérôme, Fauriat, Cyril, Kochbati, Eloïse, Orlanducci, Florence, Charbonnier, Aude, D’Incan, Evelyne, Andre, Pascale, Romagne, François, Barbarat, Bernadette, Vey, Norbert, Olive, Daniel
Foilsithe in Front Immunol (2017)

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

le Mamessier, Emilie, Sylvain, Aude, Thibult, Marie-Laure, Houvenaeghel, Gilles, Jacquemier, Jocelyne, Castellano, Rémy, Gonçalves, Anthony, André, Pascale, Romagné, François, Thibault, Gilles, Viens, Patrice, Birnbaum, Daniel, Bertucci, François, Moretta, Alessandro, Olive, Daniel
Foilsithe 2011

Recognition of peptide–MHC class I complexes by activating killer immunoglobulin-like receptors

le Stewart, C. Andrew, Laugier-Anfossi, Fanny, Vély, Frédéric, Saulquin, Xavier, Riedmuller, Jenifer, Tisserant, Agnès, Gauthier, Laurent, Romagné, François, Ferracci, Géraldine, Arosa, Fernando A., Moretta, Alessandro, Sun, Peter D., Ugolini, Sophie, Vivier, Eric
Foilsithe 2005

Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes

le Tan, Linda C, Mowat, Alastair G, Fazou , Chrysoula, Rostron , Tim, Roskell, Helen, Dunbar , P Rod, Tournay, Claire, Romagné, François, Peyrat, Marie-Alix, Houssaint, Elisabeth, Bonneville, Marc, Rickinson, Alan B, McMichael , Andrew J, Callan, Margaret FC
Foilsithe 2000

Preclinical characterization of 1-7F9, a novel human anti–KIR receptor therapeutic antibody that augments natural killer–mediated killing of tumor cells

le Romagné, Francois, André, Pascale, Spee, Pieter, Zahn, Stefan, Anfossi, Nicolas, Gauthier, Laurent, Capanni, Marusca, Ruggeri, Loredana, Benson, Don M., Blaser, Bradley W., Della Chiesa, Mariella, Moretta, Alessandro, Vivier, Eric, Caligiuri, Michael A., Velardi, Andrea, Wagtmann, Nicolai
Foilsithe 2009

Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies

le Kohrt, Holbrook E., Thielens, Ariane, Marabelle, Aurelien, Sagiv-Barfi, Idit, Sola, Caroline, Chanuc, Fabien, Fuseri, Nicolas, Bonnafous, Cécile, Czerwinski, Debra, Rajapaksa, Amanda, Waller, Erin, Ugolini, Sophie, Vivier, Eric, Romagné, François, Levy, Ronald, Bléry, Mathieu, André, Pascale
Foilsithe 2014

Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46

le Walzer, Thierry, Bléry, Mathieu, Chaix, Julie, Fuseri, Nicolas, Chasson, Lionel, Robbins, Scott H., Jaeger, Sébastien, André, Pascale, Gauthier, Laurent, Daniel, Laurent, Chemin, Karine, Morel, Yannis, Dalod, Marc, Imbert, Jean, Pierres, Michel, Moretta, Alessandro, Romagné, François, Vivier, Eric
Foilsithe 2007

IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect

le Benson, Don M., Bakan, Courtney E., Zhang, Shuhong, Collins, Shauna M., Liang, Jing, Srivastava, Shivani, Hofmeister, Craig C., Efebera, Yvonne, Andre, Pascale, Romagne, Francois, Bléry, Mathieu, Bonnafous, Cécile, Zhang, Jianying, Clever, David, Caligiuri, Michael A., Farag, Sherif S.
Foilsithe 2011

Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control

le Bléry, Mathieu, Mrabet-Kraiem, Manel, Morel, Ariane, Lhospice, Florence, Bregeon, Delphine, Bonnafous, Cécile, Gauthier, Laurent, Rossi, Benjamin, Remark, Romain, Cornen, Stéphanie, Anceriz, Nadia, Viaud, Nicolas, Trichard, Sylvia, Carpentier, Sabrina, Joulin-Giet, Alix, Grondin, Gwendoline, Liptakova, Veronika, Kim, Younghoon, Daniel, Laurent, Haffner, Aurélie, Macagno, Nicolas, Pouyet, Laurent, Perrot, Ivan, Paturel, Carine, Morel, Yannis, Steinle, Alexander, Romagné, François, Narni-Mancinelli, Emilie, Vivier, Eric
Foilsithe in Open Res Eur (2021)